eIF5A1 Inhibitors are a specialized class of chemical compounds that target and inhibit the activity of eukaryotic initiation factor 5A1 (eIF5A1), a highly conserved protein involved in the regulation of translation. eIF5A1 is unique because it is the only known protein to undergo post-translational modification by hypusination, a process that is crucial for its function in promoting the synthesis of specific proteins, particularly those involved in cell proliferation, differentiation, and stress responses. By inhibiting eIF5A1, researchers can study the detailed mechanisms of translation elongation and the role of hypusinated eIF5A1 in various cellular processes, including the synthesis of proteins that are otherwise challenging to produce or regulate within the cell.
The inhibition of eIF5A1 is particularly valuable for exploring its involvement in the regulation of proteins with proline-rich sequences, which are known to be critical for the control of cell cycle progression and apoptosis. eIF5A1 Inhibitors provide a powerful tool for dissecting the molecular pathways that rely on these specific proteins, allowing scientists to gain insights into how cells regulate essential functions like growth, division, and response to environmental stressors. Furthermore, these inhibitors offer a way to study the broader impact of translation control on cellular homeostasis and the maintenance of protein quality. By modulating eIF5A1 activity, researchers can explore how the balance of protein synthesis and degradation is maintained in the cell and how disruptions to this balance can lead to various cellular outcomes. Overall, eIF5A1 Inhibitors serve as a critical resource for advancing our understanding of the complex network of interactions that govern translation and protein synthesis in eukaryotic cells.
関連項目
Items 11 to 18 of 18 total
画面:
製品名 | CAS # | カタログ # | 数量 | 価格 | 引用文献 | レーティング |
---|---|---|---|---|---|---|
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
ドキソルビシンによるDNA損傷は、細胞が通常の機能よりもDNA修復を優先させる可能性があり、その結果、RNAi機構が抑制され、eIF2C2レベルが低下する可能性があります。 | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
カンプトテシンのトポイソメラーゼI阻害作用はDNA損傷を引き起こす可能性があり、その結果、RNAiプロセスへの重点が低下し、eIF2C2発現が低下する可能性があります。 | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $38.00 $58.00 $102.00 $202.00 | 8 | |
ゲルダナマイシンはHsp90を阻害することで、RNAiに関連するタンパク質を不安定化させる可能性があり、eIF2C2の安定性や合成の低下が含まれる可能性がある。 | ||||||
MLN7243 | 1450833-55-2 | sc-507338 | 5 mg | $340.00 | ||
TAK-243は、タンパク質翻訳を阻害することで間接的にEIF3εに影響を与えるユビキチン活性化酵素(UAE)の低分子阻害剤である。抗がん剤としての可能性が研究されている。 | ||||||
Silvestrol | 697235-38-4 | sc-507504 | 1 mg | $920.00 | ||
EIF4AIの強力な阻害剤として知られる植物Aglaia foveolataから単離された天然化合物。 | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $270.00 $465.00 $1607.00 $2448.00 $5239.00 | 4 | |
EIF4AIの阻害活性が強い、Aglaia属などのいくつかの植物から発見された別の天然化合物。 | ||||||
4E1RCat | 328998-25-0 | sc-361085 sc-361085A | 10 mg 50 mg | $189.00 $797.00 | ||
eIF4F複合体を破壊し、キャップ依存性翻訳を阻害するように設計された合成EIF4AI阻害剤。 | ||||||
eIF4E/eIF4G Interaction Inhibitor, 4EGI-1 | 315706-13-9 | sc-202597 | 10 mg | $260.00 | 14 | |
eIF4E-eIF4Gの相互作用を阻害する低分子化合物であり、それにより翻訳開始を阻害する。 |